The agenda for the 7 May 2014 Transparency Commission meeting is now available.  The Commission will examine the following medicines:

• Ceftobiprole medocaril sodium (Mabelio) - new medicine
• Certolizumab pegol (Cimzia) - new indication
• Loxapine (Adasuve) - new medicine
• Dolutegravir sodium (Tivicay) - new medicine

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-04/odj_ct_07042014_internet.pdf